Evidence so far suggests that the prevalence of long COVID in low- and middle-income countries could be similar to that of wealthier countries. For example, by some estimates, more than four million people in Brazil have long COVID.
However, an absence of research on the condition in less-wealthy countries has left advocates hamstrung: few physicians acknowledge that long COVID exists. A lack of data is also hampering efforts to search for the mechanisms of the condition and tailor treatments.
This is an audio version of our Feature Long COVID is a double curse in low-income nations — here’s why
Hosted on Acast. See acast.com/privacy for more information.
Coronapod: Waiving vaccine patents and coronavirus genome data disputes
Oldest African burial site uncovers Stone Age relationship with death
Coronapod special: The inequality at the heart of the pandemic
What fruit flies could teach scientists about brain imaging
Audio long-read: How drugmakers can be better prepared for the next pandemic
Coronapod: Kids and COVID vaccines
Meet the inflatable, origami-inspired structures
Coronapod: could COVID vaccines cause blood clots? Here's what the science says
The sanitation crisis making rural America ill
Coronapod: A whistle-blower’s quest to take politics out of coronavirus surveillance
Audio long-read: Rise of the robo-writers
Coronapod: How to define rare COVID vaccine side effects
Antimatter cooled with lasers for the first time
Coronapod: the Oxford-AstraZeneca COVID vaccine - what you need to know
Network of world's most accurate clocks paves way to redefine time
Coronapod: Why COVID antibody treatments may not be the answer
The AI that argues back
Coronapod: COVID and pregnancy - what do we know?
The smallest measurement of gravity ever recorded
Coronapod: COVID's origins and the 'lab leak' theory
Create your
podcast in
minutes
It is Free